Antiviral activity of α-helical stapled peptides designed from the HIV-1 capsid dimerization domain
2011
Background
The C-terminal domain (CTD) of HIV-1 capsid (CA), like full-length CA, forms dimers in solution and CTD dimerization is a major driving force in Gag assembly and maturation. Mutations of the residues at the CTD dimer interface impair virus assembly and render the virus non-infectious. Therefore, the CTD represents a potential target for designing anti-HIV-1 drugs.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
102
References
48
Citations
NaN
KQI